Zentalis Pharmaceuticals, Inc. - common stock (NQ:ZNTL)

2.670 +0.150 (+5.95%)

Delayed Quote Updated: 9:30 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zentalis Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 18, 2024

Via Benzinga

ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

ZNTL stock results show that Zentalis Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 28, 2024

Via Benzinga

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

Via Talk Markets

Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform

January 08, 2024

From Immunome, Inc.

Via Business Wire

Analyst Expectations for Zentalis Pharma's Future ↗

November 07, 2023

Via Benzinga

Where Zentalis Pharma Stands With Analysts ↗

August 10, 2023

Via Benzinga

Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know ↗

November 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 06, 2023

Via Benzinga

TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday ↗

November 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Around $108M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

June 21, 2023

Although US stocks closed lower on Tuesday, there were a few notable insider trades.

Via Benzinga

Analyst Expectations for Zentalis Pharma's Future ↗

June 07, 2023

Via Benzinga

Zentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b Outcomes ↗

May 26, 2023

Via Benzinga

Where Zentalis Pharma Stands With Analysts ↗

May 19, 2023

Via Benzinga

Zentalis Pharma: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More ↗

June 15, 2023

Via Benzinga

Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday ↗

June 15, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to...

Via Benzinga

Why Shares of Zentalis Pharmaceuticals Dropped This Week ↗

June 02, 2023

A rash of insider selling meant the stock gave back some of its gains from last week.

Via The Motley Fool

Stocks That Hit 52-Week Lows On Friday ↗

March 10, 2023

On Friday, 497 companies set new 52-week lows.

Via Benzinga

Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL)

January 10, 2023

From Newman Ferrara LLP

Via Business Wire

4 Analysts Have This to Say About Zentalis Pharmaceuticals ↗

November 11, 2022

Zentalis Pharmaceuticals (NASDAQ:ZNTL) has observed the following analyst ratings within the last quarter:

Via Benzinga

Oppenheimer Maintains Outperform Rating for Zentalis Pharmaceuticals: Here's What You Need To Know ↗

November 10, 2022

Oppenheimer has decided to maintain its Outperform rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) and lower its price target from $80.00 to $50.00. Shares of Zentalis Pharmaceuticals are trading up...

Via Benzinga

This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37% ↗

August 10, 2022

Via Benzinga

Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes ↗

August 10, 2022

RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday.

Via Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

Zentalis Pharmaceuticals: Q2 Earnings Insights ↗

August 09, 2022

Zentalis Pharmaceuticals (NASDAQ:ZNTL) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.

Via Benzinga

Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression

May 18, 2022

Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – Companies in the Ovarian Cancer market are spending a lot of R&D on vaccine development, therapies and studies. For the past 30...

Via FinancialNewsMedia

Topics Death

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗

July 12, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.